title: Propranolol treatment for a giant infantile brain cavernoma.
authors.forename: Maria
authors.initials: M
authors.lastname: Moschovi
authors.forename: George A
authors.initials: GA
authors.lastname: Alexiou
authors.forename: Kalliopi
authors.initials: K
authors.lastname: Stefanaki
authors.forename: Natalia
authors.initials: N
authors.lastname: Tourkantoni
authors.forename: Neofytos
authors.initials: N
authors.lastname: Prodromou
mesh_terms: D018952:Antigens, CD34 / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001808:Blood Vessels / Q000378:metabolism / Q000473:pathology; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D020786:Hemangioma, Cavernous, Central Nervous System / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D007223:Infant; D007501:Iron / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D008297:Male; D011433:Propranolol / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018952:Antigens, CD34; D000970:Antineoplastic Agents; D011433:Propranolol; D007501:Iron